Results 11 to 20 of about 790,254 (306)

RESULTS OF THE CLINICAL TRIAL FOURIER. NEW OPPORTUNITIES FOR TREATMENT OF VERY HIGH CARDIOVASCULAR RISK PATIENTS

open access: yesРоссийский кардиологический журнал, 2017
Advisory Board of Russian Society of Cardiology (RSC), Russian National Atherosclerosis Society (RNAS), Russian Society of Cardiosomatic Rehabilitation and Secondary Prevention (RSCRSP)
Advisory Board
doaj   +1 more source

Atrial fibrillation: Primary prevention, secondary prevention, and prevention of thromboembolic complications: Part 2

open access: yesFrontiers in Cardiovascular Medicine, 2023
Atrial fibrillation (AF), the most common sustained cardiac arrhythmia, once thought to be benign as long as the ventricular rate was controlled, is associated with significant cardiac morbidity and mortality.
Richard G. Trohman   +2 more
doaj   +1 more source

Atrial fibrillation: primary prevention, secondary prevention, and prevention of thromboembolic complications: part 1

open access: yesFrontiers in Cardiovascular Medicine, 2023
Atrial fibrillation (AF), is the most common sustained cardiac arrhythmia. It was once thought to be benign as long as the ventricular rate was controlled, however, AF is associated with significant cardiac morbidity and mortality.
Richard G. Trohman   +2 more
doaj   +1 more source

Integration of Metabolomics and Transcriptomics Reveals the Therapeutic Mechanism Underlying Paeoniflorin for the Treatment of Allergic Asthma

open access: yesFrontiers in Pharmacology, 2019
Objectives: Asthma is a chronic airway inflammatory disease, which is characterized by airway remodeling, hyperreactivity and shortness of breath. Paeoniflorin is one of the major active ingredients in Chinese peony, which exerts anti-inflammatory and ...
Qiyang Shou   +12 more
doaj   +1 more source

An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey

open access: yesAnatolian Journal of Cardiology, 2022
Background: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study trial has been the largest study ever conducted among patients in Turkey regarding aspirin treatment.
Kadriye Memiç Sancar   +17 more
doaj   +1 more source

Depression Literacy of Women and Girls in Terms of Prevention and Interventions

open access: yesIranian Journal of Psychiatry, 2021
Objective: Recognizing the status of mental health literacy among women and girls as effective and key individuals in family and society seem to be essential.
Azadeh Sayarifard   +4 more
doaj   +1 more source

Antiplatelets in secondary stroke prevention

open access: yesFrontiers in Neurology, 2011
The aim of this review is to provide evidence-based recommendations on the secondary prevention of atherothrombotic ischemic stroke. Antiplatelets are the major therapy for the secondary stroke prevention.
Olga eShulga, Natan eBornstein
doaj   +1 more source

Secondary prevention of hidradenitis suppurativa

open access: yesDermatology Reports, 2019
Hidradenitis suppurativa (HS) is a multifactorial disease with many facets of uncertain importance for optimal treatment and prevention. In order to explore options for secondary prevention in HS, we randomly and retrospectively selected 40 patients with
Hjalmar Kurzen, Marina Kurzen
doaj   +1 more source

DTC-Flow: a flow cytometry-based detection platform for characterizing bone marrow disseminated tumor cells in breast cancer

open access: yesnpj Breast Cancer
The presence of bone marrow (BM) disseminated tumor cells (DTCbm) identifies early-stage breast cancer patients at increased risk of recurrence and poorer overall survival.
Elizabeth M. Chislock   +35 more
doaj   +1 more source

Potential Early Risk Biomarkers for Reduced Forced Expiratory Volume in Children Post‐Hematopoietic Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT We sought to identify potential early risk biomarkers for lung disease in children post‐allogeneic HCT. Patients with pulmonary function tests 3 months post‐transplant and plasma samples between days 7 and 14 post‐HCT were included. Six of 27 subjects enrolled had reduced forced expiratory volume 1 (FEV1) z scores.
Isabella S. Small   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy